Norwood Abbey Limited Acquires Global Rights To Next Generation Of Laser Eye Surgery Technology
10/19/2005 5:11:10 PM
Norwood Abbey Limited (other-OTC: NABYY, NABYF; ASX: NAL) today announced today that the company has exclusively licensed the worldwide rights to Epi-LASIK, the technology behind the next generation of laser eye surgery. In addition, Norwood has purchased the global license and associated approvals for key components of Epi-LASIK: the Centurion SES(TM) System and EpiEdge(TM) (epikeratome separator), from CIBA Vision, a wholly owned subsidiary of Novartis AG (NYSE:NVS).
comments powered by